Cited by 1,141Schizophrenia research and treatmentNicotinic Acetylcholine Receptors StudyGenetic Associations and Epidemiology

The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.

Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus

Open access

Freedman, Robert, Coon, Hilary, Myles-Worsley, Marina, Orr-Urtreger, Avi, Olincy, Ann, Davis, Ashley, Polymeropoulos, Mihael, Holik, John, Hopkins, Jan, Hoff, Mark, Rosenthal, Judy, Waldo, Merilyne C., Reimherr, Fred, Wender, Paul, Yaw, Jeffrey, Young, David A., Breese, Charles R., Adams, Catherine, Patterson, David, Adler, Lawrence E., Kruglyak, Leonid, Leonard, Sherry, Byerley, William·1997·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.94.2.587PMC PMC19557

Open this paper in CoChat — free account

Abstract

Inheritance of a defect in a neuronal mechanism that regulates response to auditory stimuli was studied in nine families with multiple cases of schizophrenia. The defect, a decrease in the normal inhibition of the P50 auditory-evoked response to the second of paired stimuli, is associated with attentional disturbances in schizophrenia. Decreased P50 inhibition occurs not only in most schizophrenics, but also in many of their nonschizophrenic relatives, in a distribution consistent with inherited vulnerability for the illness. Neurobiological investigations in both humans and animal models indicated that decreased function of the α7-nicotinic cholinergic receptor could underlie the physiological defect. In the present study, a genome-wide linkage analysis, assuming autosomal dominant transmission, showed that the defect is linked [maximum logarithm of the odds (lod) score = 5.3 with zero recombination] to a dinucleotide polymorphism at chromosome 15q13-14, the site of the α7-nicotinic receptor. Despite many schizophrenics’ extremely heavy nicotine use, nicotinic receptors were not previously thought to be involved in schizophrenia. The linkage data thus provide unique new evidence that the α7-nicotinic receptor gene may be responsible for the inheritance of a pathophysiological aspect of the illness.

Integrity signals

Registry

Crossref · 10.1073/pnas.94.2.587

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Research Diagnostic Criteria
Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,946
A Diagnostic Interview
Endicott, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310043002 · Cited by 5,686
Parametric and nonparametric linkage analysis: a unified multipoint approach.
Kruglyak, L., Daly, M. J., Daly, M. J., & Lander, E. S. (1996) · PubMed Central · Cited by 2,883
Self-citation
Strategies for multilocus linkage analysis in humans.
Lathrop, M. G., Lalouel, J.-M., Julier, C., & Ott, J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.11.3443 · Cited by 2,560
Progress in experimental personality research
Maher, W. B., & Maher, B. A. (1964) · Academic Press eBooks · Cited by 2,347
Schizotaxia, schizotypy, schizophrenia.
Meehl, P. E. (1962) · American Psychologist · doi:10.1037/h0041029 · Cited by 2,036
Analysis of Human Genetic Linkage.
Edwards, A. W. F., & Ott, J. (1992) · Biometrics · doi:10.2307/2532370 · Cited by 1,691
Gating and Habituation of the Startle Reflex in Schizophrenic Patients
Braff, D. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820030038005 · Cited by 1,027
A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homo-oligomeric channel blocked by α-BTX
Couturier, S., Bertrand, D., Matter, J., Hernandez, M., Bertrand, S., Millar, N. S., Valera, S., BARKAS, T., & Ballivet, M. (1990) · Neuron · doi:10.1016/0896-6273(90)90344-f · Cited by 941
Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia.
Adler, L. E., Pachtman, E., Franks, R. D., Pecevich, M., Waldo, M. C., & Freedman, R. (1982) · PubMed · Cited by 896
Self-citation

Flagged first, then by citations

Show all 63 references

1 of the 63 references couldn’t be matched to a known paper.

Research works printed but not linked: 8

J-M Lalouel Am J Hum Genet 37, 700–718 (1985).
L E Adler, E Pachtman, R Franks, M Pecevich, M C Waldo, R Freedman Biol Psychiatry 17, 639–654 (1982).
W R Goff, P D Williamson, C VanGilder, R Allison, T C Fisher Prog Clin Neurophysiol 7, 126–145 (1980).
L Kruglyak, M J Daly, M P Reeve-Daly, E S Lander Am J Hum Genet 58, 1347–1363 (1996).
L Kruglyak, E S Lander Am J Hum Genet 57, 519–527 (1995).
M Melissari, G Giordano, P Crafa, M Martella, R Ricci Pathologica 87, 78–81 (1995).
L K Casaubon, M Melanson, I Lopes-Cendes, C Marineau, E Andersmann, F Andersmann, J Weissenbach, C Prevost, J P Bouchard, J Matheiu, G A Rouleau Am J Hum Genet 58, 28–34 (1996).
10.1002/(SICI)1096-8628(19960409)67:2<154::AID-AJMG5>3.0.CO;2-S · DOI

Sorted by citations

Items 301–400 of 1,000

Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C>T polymorphism
Tiwari, A. K., Deshpande, S. N., Lerer, B., Nimgaonkar, V. L., & Thelma, B. K. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500415 · Cited by 87
Nicotine improves delayed recognition in schizophrenic patients
Myers, C. S., Robles, O., Kakoyannis, A. N., Sherr, J. D., Avila, M. T., Blaxton, T. A., & Thaker, G. K. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1764-8 · Cited by 87
Validation and Extension of the Endophenotype Model in ADHD Patterns of Inheritance in a Family Study of Inhibitory Control
Goos, L. M., Crosbie, J., Payne, S., & Schachar, R. J. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08040621 · Cited by 89
Neuroadaptations to chronic exposure to drugs of abuse: Relevance to depressive symptomatology seen across psychiatric diagnostic categories
Markou, A., & Kenny, P. J. (2002) · Neurotoxicity Research · doi:10.1080/10298420290023963 · Cited by 87
P50 sensory gating in adolescents from a pacific island isolate with elevated risk for schizophrenia
Myles‐Worsley, M., Ord, L. M., Blailes, F., Ngiralmau, H., & Freedman, R. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.12.006 · Cited by 86
Self-citation
Activation of the canonical Wnt pathway by the antipsychotics haloperidol and clozapine involves dishevelled‐3
Sutton, L. P., Honardoust, D., Mouyal, J., Rajakumar, N., & Rushlow, W. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04527.x · Cited by 86
Pharmaco-genetically guided treatment of recurrent rage outbursts in an adult male with 15q13.3 deletion syndrome
Cubells, J. F., DeOreo, E. H., Harvey, P. D., Garlow, S. J., Garber, K. B., Adam, M. P., & Martin, C. L. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33917 · Cited by 87
Search for cognitive trait components of schizophrenia reveals a locus for verbal learning and memory on 4q and for visual working memory on 2q
Paunio, T. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh184 · Cited by 86
Dominant partial epilepsies: A clinical, electrophysiological and genetic study of 19 European families
Picard, F. (2000) · Brain · doi:10.1093/brain/123.6.1247 · Cited by 86
Development of ligands for in vivo imaging of cerebral nicotinic receptors
Sihver, W., Nordberg, A. K., Långström, B., Mukhin, A. G., Koren, A. O., Kimes, A. S., & London, E. D. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00209-6 · Cited by 86
L INKAGE A NALYSIS IN P SYCHIATRIC D ISORDERS : The Emerging Picture
Sklar, P. B. (2002) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.3.022502.103141 · Cited by 86
Short-Term Tropisetron Treatment and Cognitive and P50 Auditory Gating Deficits in Schizophrenia
Zhang, X., Liu, L., Liu, S., Hong, X., Chen, D. C., Xiu, M. H., Yang, F. D., Zhang, Z., Zhang, X., Kosten, T. A., et al. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11081289 · Cited by 85
The Duplicated α7 Subunits Assemble and Form Functional Nicotinic Receptors with the Full-length α7
Wang, Y., Xiao, C., Indersmitten, T., Freedman, R., Leonard, S. S., & Lester, H. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.582858 · Cited by 86
Self-citation
The interaction between maternal immune activation and alpha 7 nicotinic acetylcholine receptor in regulating behaviors in the offspring
Wu, W., Adams, C. E., Stevens, K. E., Chow, K.-H. K., Freedman, R., & Patterson, P. H. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.02.005 · Cited by 89
Self-citation
Evidence for linkage disequilibrium between the alpha 7‐nicotinic receptor gene (CHRNA7) locus and schizophrenia in Azorean families*
Xu, J., Pato, M. T., Torre, C. D., Medeiros, H., Carvalho, C. B., Basile, V. S., Bauer, A., Dourado, A., Valente, J., Soares, M. J., et al. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1549 · Cited by 84
Dysregulation of thalamic sensory ‘transmission’ in schizophrenia: neurochemical vulnerability to hallucinations
Behrendt, R. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881105057696 · Cited by 83
Amphetamine disrupts P50 suppression in normal subjects
Light, G. A., Malaspina, D., Geyer, M. A., Luber, B. M., Coleman, E. A., Sackeïm, H. A., & BRAFF, D. L. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00034-7 · Cited by 83
Comparison of polymorphisms in the α7 nicotinic receptor gene and its partial duplication in schizophrenic and control subjects
Gault, J., Hopkins, J. A., Berger, R., Drebing, C. J., Logel, J., Walton, C., Short, M., Vianzon, R., D, A. O. M., Ross, R. G., et al. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20061 · Cited by 83
Self-citation
Suggestive evidence for linkage of schizophrenia to markers at chromosome 15q13–14 in Taiwanese families
Liu, C., Hwu, H., Lin, M., Ouyang, W., Lee, S. F. ‐., Fann, C. S. J., Wong, S., & Hsieh, S.-H. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1547 · Cited by 83
Sensory gating impairment associated with schizophrenia persists into REM sleep
Kisley, M. A., D, A. O. M., Robbins, E., Polk, S. D., Adler, L. E., Waldo, M. C., & Freedman, R. (2003) · Psychophysiology · doi:10.1111/1469-8986.00004 · Cited by 83
Self-citation
Cholinergic contributions to the cognitive symptoms of schizophrenia and the viability of cholinergic treatments
Sarter, M. F., Lustig, C., & Taylor, S. F. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.12.001 · Cited by 82
The genetic epidemiology of schizophrenia and of schizophrenia spectrum disorders
Lichtermann, D., Karbe, E., & Maier, W. (2000) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060070005 · Cited by 82
Detection of Functional Nicotinic Receptors Blocked by α-Bungarotoxin on PC12 Cells and Dependence of Their Expression on Post-Translational Events
Blumenthal, E., Conroy, W. G., Romano, S. J., Kassner, P. D., & Berg, D. K. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-16-06094.1997 · Cited by 82
Synaptic Dysfunction in Schizophrenia
Yin, D., Chen, Y., Sathyamurthy, A., Xiong, W., & Mei, L. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-3-7091-0932-8_22 · Cited by 85
The emerging spectrum of allelic variation in schizophrenia: current evidence and strategies for the identification and functional characterization of common and rare variants
Mowry, B. J., & Gratten, J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.34 · Cited by 82
Targeting alpha-7 nicotinic neurotransmission in schizophrenia: A novel agonist strategy
Deutsch, S. I., Schwartz, B. L., Schooler, N. R., Brown, C. H., Rosse, R. B., & Rosse, S. M. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.05.023 · Cited by 81
A Test of the Cognitive Self-Medication Hypothesis of Tobacco Smoking in Schizophrenia
Hahn, B., Harvey, A. N., Concheiro, M., Huestis, M. A., Holcomb, H. H., & Gold, J. M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.017 · Cited by 81
P50 Suppression in Individuals at Risk for Schizophrenia: The Convergence of Clinical, Familial, and Vulnerability Marker Risk Assessment
Cadenhead, K. S., Light, G. A., Shafer, K. M., & BRAFF, D. L. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.003 · Cited by 81
Review of neurophysiological findings in patients with schizophrenia
Onitsuka, T., Oribe, N., Nakamura, I., & Kanba, S. (2013) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12090 · Cited by 85
Nicotinic Mechanisms in the Treatment of Psychotic Disorders: A Focus on the α7 Nicotinic Receptor
D, A. O. M., & Freedman, R. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25758-2_8 · Cited by 80
Self-citation
P50, N100, and P200 Auditory Sensory Gating Deficits in Schizophrenia Patients
Shen, C.-L., Chou, T., Lai, W., Hsieh, M. H., Liu, C., Liu, C., & Hwu, H. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00868 · Cited by 80
Clinical neurochemistry: developments in dementia research based on brain bank material
Perry, E. K., COURT, J. A., Goodchild, R. E., Griffiths, M., Jaros, E., Johnson, M. K., Lloyd, S. R., Piggott, M. A., Spurden, D., Ballard, C. G., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050102 · Cited by 80
Gene targets related to phospholipid and fatty acid metabolism in schizophrenia and other psychiatric disorders: an update
Bennett, C. N., & Horrobin, D. F. (2000) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2000.0191 · Cited by 80
Examination of genetic linkage of chromosome 15 to schizophrenia in a large Veterans Affairs Cooperative Study sample
Tsuang, D. W., Skol, A. D., Faraone, S. V., Bingham, S. F., Young, K. A., Prabhudesai, S., Haverstock, S. L., Mena, F., Menon, A. S., Bisset, D., et al. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1550 · Cited by 80
Effects of Temporal Variability on P50 and the Gating Ratio in Schizophrenia
Patterson, J. V., Jin, Y., Gierczak, M., Hetrick, W. P., Potkin, S. G., Bunney, W. E., & Sandman, C. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.57 · Cited by 79
Deficit psychopathology and a paradigm shift in schizophrenia research
Carpenter, W. T., Arango, C., Buchanan, R. W., & Kirkpatrick, B. W. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00088-8 · Cited by 79
Positive and Negative Effects of Alcohol and Nicotine and Their Interactions: A Mechanistic Review
Hurley, L. L., Taylor, R. E., & Tizabi, Y. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9275-6 · Cited by 83
Association study of CHRFAM7A copy number and 2bp deletion polymorphisms with schizophrenia and bipolar affective disorder
Flomen, R. H., Collier, D. A., Osborne, S., Munro, J., Breen, G. D., Clair, D. S., & MAKOFF, A. J. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30306 · Cited by 79
Cigarette smoking and psychotic symptoms in bipolar affective disorder
Corvin, A. P., O’Mahony, E., O’Regan, M., Comerford, C., O'Connell, R. M., Craddock, N. J., & Gill, M. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.179.1.35 · Cited by 79
A Practical and Efficient Synthesis of the Selective Neuronal Acetylcholine-Gated Ion Channel Agonist (S)-(−)-5-Ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine Maleate (SIB-1508Y)
Bleicher, L. S., Cosford, N. D. P., Herbaut, A., MCCALLUM, J. S., & McDonald, I. A. (1998) · The Journal of Organic Chemistry · doi:10.1021/jo971572d · Cited by 79
Polymorphically duplicated genes: their relevance to phenotypic variation in humans
Buckland, P. R. (2003) · Annals of Medicine · doi:10.1080/07853890310001276 · Cited by 78
Differential effects of cigarette smoking on performance of a smooth pursuit and a saccadic eye movement task in schizophrenia
D, A. O. M., Johnson, L. L., & Ross, R. G. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00022-2 · Cited by 80
Associations of P50 suppression and desensitization with perceptual and cognitive features of “unreality” in schizotypy
Croft, R. J., Lee, A., Bertolot, J., & Gruzelier, J. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01082-4 · Cited by 76
A Concordance Study of Three Electrophysiological Measures in Schizophrenia
la Chapelle, S. L.-D., Nkam, I., Houy‐Durand, E., Belmont, A., Ménard, J.-F., Roussignol, A.-C., Siwek, O., Mezerai, M., Guillermou, M., Fouldrin, G., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.3.466 · Cited by 76
Discovery of 4-(5-Methyloxazolo[4,5- b ]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a Novel α7 Nicotinic Acetylcholine Receptor Agonist for the Treatment of Cognitive Disorders in Schizophrenia: Synthesis, SAR Development, and in Vivo Efficacy in Cognition Models
O’Donnell, C. J., Rogers, B. N., Bronk, B. S., Bryce, D. K., Coe, J. W., Cook, K. K., Duplantier, A. J., Evrard, E., Hajós, M., Hoffmann, W. E., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9015075 · Cited by 75
Sensorimotor Gating is Associated with CHRNA3 Polymorphisms in Schizophrenia and Healthy Volunteers
Petrovsky, N., Quednow, B. B., Ettinger, U., Schmechtig, A., Mößner, R., Collier, D. A., Kühn, K.-U., Maier, W., Wagner, M., & Kumari, V. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.12 · Cited by 77
Nicotinic systems in central nervous systems disease: degenerative disorders and beyond
NEWHOUSE, P. A., & Kelton, M. (2000) · Pharmaceutica Acta Helvetiae · doi:10.1016/s0031-6865(99)00047-3 · Cited by 76
Distinct M50 and M100 auditory gating deficits in schizophrenia
Hanlon, F. M., Miller, G. A., Thoma, R. J., Irwin, J., Jones, A. P., Moses, S. N., Huang, M., Weisend, M. P., Paulson, K. M., Edgar, J. C., et al. (2005) · Psychophysiology · doi:10.1111/j.1469-8986.2005.00299.x · Cited by 74
Self-citation
Neuronal nicotinic acetylcholine receptors: From the genetic analysis to neurological diseases
Steinlein, O. K., & Bertrand, D. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.012 · Cited by 74
A genotype-controlled analysis of plasma dopamine β-hydroxylase in healthy and alcoholic subjects: evidence for alcohol-related differences in noradrenergic function
Köhnke, M. D., Zabetian, C. P., Anderson, G., Kolb, W., Gaertner, I., Buchkremer, G., Vonthein, R., Schick, S., Lutz, U. C., Köhnke, A. M., et al. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01427-0 · Cited by 73
Targeting α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia
Hajós, M., & Rogers, B. N. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210790361434 · Cited by 73
Enhanced magnetic auditory steady-state response in early Alzheimer’s disease
Osipova, D. V., Pekkonen, E., & Ahveninen, J. (2006) · Clinical Neurophysiology · doi:10.1016/j.clinph.2006.05.034 · Cited by 73
Evidence for the involvement of the hippocampus in the pathophysiology of schizophrenia
Gothelf, D., Soreni, N., Nachman, R., Tyano, S., Hiss, Y., Reiner, O., & Weizman, A. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00097-3 · Cited by 73
Cholinergic Axons Modulate GABAergic Signaling among Hippocampal Interneurons via Postsynaptic α7 Nicotinic Receptors
Wanaverbecq, N., Semyanov, A. V., Pavlov, I., Walker, M. C., & Kullmann, D. M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1732-07.2007 · Cited by 74
Chapter 4. Personality Disorders and Relational Disorders: A Research Agenda for Addressing Crucial Gaps in DSM
First, M. B., Bell, C. C., Cuthbert, B. C., Krystal, J. H., Malison, R. T., Offord, D. R., Reiss, D., Shea, M. T., Widiger, T., & Wisner, K. L. (2002) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9780890427644.lg04 · Cited by 73
Analysis ofALDH1A2,CYP26A1,CYP26B1,CRABP1, andCRABP2 in human neural tube defects suggests a possible association with alleles inALDH1A2
Deak, K. L., Dickerson, M. E., Linney, E. A., Enterline, D. S., George, T. M., Melvin, E. C., Graham, F. L., Siegel, D. G., Hammock, P., Mehltretter, L., et al. (2005) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20183 · Cited by 72
Auditory event-related potential of subjects with suspected pre-psychotic state and first‐episode psychosis
Hsieh, M. H., Shan, J., Huang, W., Cheng, W.-C., Chiu, M., Jaw, F., Hwu, H., & Liu, C. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.06.021 · Cited by 72
P50 Sensory Gating in Multiplex Schizophrenia Families From a Pacific Island Isolate
Myles‐Worsley, M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.12.2007 · Cited by 72
Self-citation
Genetics of Psychosis in Alzheimer's Disease: A Review
DeMichele‐Sweet, M. A. A., & Sweet, R. A. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1274 · Cited by 71
The Therapeutic Potential of α7 Nicotinic Acetylcholine Receptor (α7 nAChR) Agonists for the Treatment of the Cognitive Deficits Associated with Schizophrenia
Beinat, C., Banister, S. D., Herrera, M., Law, V., & Kassiou, M. (2015) · CNS Drugs · doi:10.1007/s40263-015-0260-0 · Cited by 68
Periodic catatonia: confirmation of linkage to chromosome 15 and further evidence for genetic heterogeneity
Stöber, G., Seelow, D., Rüschendorf, F., Ekici, A. B., Beckmann, H., & Reis, A. (2002) · Human Genetics · doi:10.1007/s00439-002-0805-4 · Cited by 71
Genetics and genomics of behavioral and psychiatric disorders
Inoue, K., & Lupski, J. R. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00057-1 · Cited by 71
CHRNA7 and CHRFAM7A mRNAs: Co-Localized and Their Expression Levels Altered in the Postmortem Dorsolateral Prefrontal Cortex in Major Psychiatric Disorders
Kunii, Y., Zhang, W., Xu, Q., Hyde, T. M., McFadden, W. C., Shin, J. H., Deep‐Soboslay, A., Ye, T., Li, C., Kleinman, J. E., et al. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14080978 · Cited by 70
Single-Channel and Structural Foundations of Neuronal α7 Acetylcholine Receptor Potentiation
daCosta, C. J. B., Free, C. R., Corradi, J., Bouzat, C., & Sine, S. M. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2652-11.2011 · Cited by 73
Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: A proof-of-mechanism study
Winterer, G., Gallinat, J., Brinkmeyer, J., Musso, F., Kornhuber, J., Thuerauf, N., Rujescu, D., Favis, R., Sun, Y., Franc, M. A., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.040 · Cited by 70
Contribution of nicotinic receptors to the function of synapses in the central nervous system: The action of choline as a selective agonist of α7 receptors
Albuquerque, E. X., Pereira, E. F. R., Braga, M. F. M., & Alkondon, M. (1998) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(98)80039-9 · Cited by 70
Inhibition of Neuronal Nicotinic Acetylcholine Receptor Channels Expressed in Xenopus Oocytes by β-Amyloid1–42 Peptide
Lamb, P. W., Melton, M. A., & Yakel, J. L. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:27:1:013 · Cited by 70
Familial aggregation of psychotic symptoms in a replication set of 69 bipolar disorder pedigrees
Potash, J. B., Chiu, Y., MacKinnon, D. F., Miller, E. B., Simpson, S. G., McMahon, F. J., McInnis, M. G., & DePaulo, J. R. (2002) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.10761 · Cited by 70
Nicotinic acetylcholine receptor α4 subunit gene polymorphism and attention deficit hyperactivity disorder
Kent, L., Middle, F., Hawi, Z., Fitzgerald, M., Gill, M., Feehan, C., & Craddock, N. J. (2001) · Psychiatric Genetics · doi:10.1097/00041444-200103000-00007 · Cited by 71
Effects of Zn 2+ on wild and mutant neuronal α 7 nicotinic receptors
Palma, E., Maggi, L., Miledi, R., & Eusebi, F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10246 · Cited by 70
Nicotinic agonist-induced improvement of vigilance in mice in the 5-choice continuous performance test
Young, J. W., Meves, J. M., & Geyer, M. A. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.11.028 · Cited by 69
Neuropsychological deficits are associated with smoking cessation treatment failure in patients with schizophrenia
Dolan, S. L. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.01.006 · Cited by 69
Allosteric modulation of α7 nicotinic receptors selectively depolarizes hippocampal interneurons, enhancing spontaneous GABAergic transmission
Arnáiz‐Cot, J. J., Gonzalez, J., Sobrado, M., Baldelli, P., Carbone, E., Gandı́a, L., Garcı́a, A. G., & Hernández-Guijo, J. M. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06077.x · Cited by 69
Nicotine reduces antisaccade errors in task impaired schizophrenic subjects
Larrison, A. L., MATORIN, A. A., & Sereno, A. B. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.01.002 · Cited by 69
Prenatal nicotine exposure and risk of schizophrenia among offspring in a national birth cohort
Niemelä, S., Sourander, A., Surcel, H.-M., Hinkka-Yli-Salomäki, S., McKeague, I. W., Cheslack-Postava, K., & Brown, A. S. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15060800 · Cited by 68
Activation of α7 acetylcholine receptors augments stimulation‐induced hippocampal theta oscillation
Siok, C. J., Rogers, J. A., Kocsis, B., & Hajós, M. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04560.x · Cited by 68
Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trial
Freudenreich, O., Herz, L. R., Deckersbach, T., Evins, A. E., Henderson, D. C., Cather, C., & GOFF, D. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2235-1 · Cited by 68
Linkage of M5 Muscarinic and α7-Nicotinic Receptor Genes on 15q13 to Schizophrenia
Luca, V. D., Wang, H., Squassina, A., Wong, G., Yeomans, J. S., & Kennedy, J. L. (2004) · Neuropsychobiology · doi:10.1159/000079102 · Cited by 68
Cigarette Smoking in Male Patients with Chronic Schizophrenia in a Chinese Population: Prevalence and Relationship to Clinical Phenotypes
Zhang, X., Liang, J. F., Chen, D. C., Xiu, M. H., He, J., Cheng, W., Wu, Z., Yang, F. D., Haile, C. N., Sun, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030937 · Cited by 67
Functional α7‐containing nicotinic receptors of NG2‐expressing cells in the hippocampus
Vélez-Fort, M., Audinat, E., & Angulo, M. C. (2009) · Glia · doi:10.1002/glia.20834 · Cited by 69
The promoter −194 C polymorphism of the nicotinic alpha 7 receptor gene has a protective effect against the P50 sensory gating deficit
Houy, E., Raux, G., Thibaut, F., Belmont, A., Demily, C., Allio, G., Haouzir, S., Fouldrin, G., Petit, M., Frébourg, T., et al. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001443 · Cited by 67
Hallucinations: Synchronisation of thalamocortical γ oscillations underconstrained by sensory input
Behrendt, R. (2003) · Consciousness and Cognition · doi:10.1016/s1053-8100(03)00017-5 · Cited by 67
Random Mutagenesis Screen for Dominant Behavioral Mutations in Mice
Nolan, P. M., Kapfhamer, D., & Bućan, M. (1997) · Methods · doi:10.1006/meth.1997.0545 · Cited by 67
An auditory processing abnormality specific to liability for schizophrenia
Force, R. B., Venables, N. C., & Sponheim, S. R. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.04.038 · Cited by 66
Genomic imprinting in the brain
Keverne, E. B. (1997) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(97)80023-2 · Cited by 66
A New Role for Endophenotypes in the GWAS Era: Functional Characterization of Risk Variants
Hall, M.-H. (2010) · Harvard Review of Psychiatry · doi:10.3109/10673220903523532 · Cited by 66
New Targets for Prevention of Schizophrenia: Is It Time for Interventions in the Premorbid Phase?
Seidman, L. J., & Nordentoft, M. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv050 · Cited by 65
Neurocognitive endophenotypes in schizophrenia: Modulation by nicotinic receptor systems
Mackowick, K. M., Barr, M. S., Wing, V. C., Rabin, R. A., Ouellet‐Plamondon, C., & George, T. P. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.07.010 · Cited by 65
P50 inhibitory gating deficit is correlated with the negative symptomatology of schizophrenia
la Chapelle, S. L.-D., Levillain, D., Ménard, J.-F., Elst, A. V. D., Allio, G., Haouzir, S., Dollfus, S., Campion, D., & Thibaut, F. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2003.04.001 · Cited by 65
A transcranial magnetic stimulation study of abnormal cortical inhibition in schizophrenia
Fitzgerald, P. B., Brown, T. L., Marston, N., Oxley, T. J., de Castella, A. R., Daskalakis, Z. J., & Kulkarni, J. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00094-5 · Cited by 65
Clinical phenotypes associated with DISC1, a candidate gene for schizophrenia
Blackwood, D., & Muir, W. J. (2004) · Neurotoxicity Research · doi:10.1007/bf03033294 · Cited by 65
Spatial working memory deficits in schizophrenia patients and their first degree relatives from Palau, Micronesia
Myles‐Worsley, M., & Park, S. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10644 · Cited by 65
Self-citation
Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism
Tiwari, A. K., Deshpande, S. N., Rao, A. R., Triptish Bhatia, A., Mukit, S. R., Shriharsh, V., Lerer, B., Nimagaonkar, V. L., & Thelma, B. K. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500282 · Cited by 65
Psychophysiological measures of (dis)inhibition as liability indicators for schizophrenia
Clementz, B. A. (1998) · Psychophysiology · doi:10.1111/1469-8986.3560648 · Cited by 65
Eye movement and neuropsychological studies in first-degree relatives of schizophrenic patients
RYBAKOWSKI, J. K., & Borkowska, A. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00357-7 · Cited by 64
Event-related potentials and genetic risk for schizophrenia
Winterer, G., Egan, M. F., Rädler, T., Coppola, R., & Weinberger, D. R. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01072-1 · Cited by 64
Cognitive Deficits in Schizophrenia: Focus on Neuronal Nicotinic Acetylcholine Receptors and Smoking
Ochoa, E. L. M., & Lasalde‐Dominicci, J. A. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9149-x · Cited by 64
Imprinted genes and mental dysfunction
Davies, W., Isles, A. R., & Wilkinson, L. S. (2001) · Annals of Medicine · doi:10.3109/07853890108995956 · Cited by 65
Evidence for a role of nicotinic acetylcholine receptors in schizophrenia
Catherine, E. A. (2007) · Frontiers in bioscience · doi:10.2741/2424 · Cited by 63
Genome-Wide Association Study of Treatment Refractory Schizophrenia in Han Chinese
Liou, Y., Wang, H.-H., Lee, M. M., Wang, S., Chiang, H., Chen, C., Lin, C., Chung, M.-S., Kuo, C.-C., Liao, D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033598 · Cited by 63

Authors: Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., Rosenthal, J., Waldo, M. C., Reimherr, F., Wender, P., Yaw, J., Young, D. A., Breese, C. R., Adams, C., Patterson, D., Adler, L. E., Kruglyak, L., Leonard, S., & Byerley, W.
Affiliations: Baylor College of Medicine (US)
Departments of Psychiatry, Pharmacology, Biochemistry, and Preventive Medicine and Biophysics, University of Colorado School of Medicine, Denver Veterans Affairs Medical Center, and Eleanor Roosevelt Institute for Cancer Research, Denver, CO 80262; Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT 84132; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030-3498; National Center for Human Genome Research/National Institutes of...
ORCID: Freedman, Robert
Coon, Hilary
Polymeropoulos, Mihael
Young, David A.
Breese, Charles R.
Patterson, David
Kruglyak, Leonid
Byerley, William
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 1997-01-21
Volume: 94
Issue: 2
Pages: 587-592
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.94.2.587
PMC: PMC19557
OpenAlex: W2144671685
Cited by: 1,141
References: 63
Citations by year: 2026: 3 · 2025: 5 · 2024: 6 · 2023: 7 · 2022: 10 · 2021: 11 · 2020: 16 · 2019: 15 · 2018: 6 · 2017: 14 · 2016: 19 · 2015: 46 · 2014: 25 · 2013: 28 · 2012: 39
FWCI: 62.17
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Department of Veterans Affairs
National Institutes of Health (5k02mh001089-03, 1f32mh010168-01, DA09457)
National Institute on Aging (T32AG000029)
National Institute of Mental Health (MH-44212, P50MH044212, MH01089, MH-10168-F32)
National Institute on Drug Abuse (R01DA009457)
National Center for Research Resources (P41RR003655, M01RR000064)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords: schizophrenia, alpha7 nicotinic acetylcholine receptor, genetic linkage, autosomal dominant inheritance, attention deficits, family-based genetic study, nicotine use
MeSH terms: Auditory Perception, Chromosomes, Human, Pair 15, Evoked Potentials, Female, Genes, Genetic Markers, Humans, Genetic Linkage, Male, Pedigree, Receptors, Nicotinic, Schizophrenia, Chromosomes, Artificial, Yeast

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks